The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
MedPage Today on MSN19h
FTC Sues Top Pharmacy Benefit Managers Over Insulin PricesThe federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...
The Washington Post on MSN22h
FTC sues pharmacy insurance managers, alleging unfair drug pricesAccording to the FTC, the three largest PBMs — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — used their power to exclude cheaper insulin products from the menu of ...
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback